Literature DB >> 9687100

Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.

L J Teng1, P R Hsueh, Y C Chen, S W Ho, K T Luh.   

Abstract

The in-vitro susceptibilities of 13 antimicrobial agents were determined for 207 isolates of viridans group streptococci recovered from patients with significant infections in Taiwan during 1995 and 1997. Variable degrees of susceptibility existed among nine species. High-level penicillin resistance (MIC > or = 4.0 mg/L) was found most frequently in Streptococcus oralis (35%), followed by Streptococcus mitis (20%) and Streptococcus salivarius (8%). However, S. salivarius showed the lowest rate of susceptibility to penicillin (50%). Macrolide resistance also occurred most frequently in S. oralis isolates (55%) but in none of Streptococcus mutans. Penicillin and macrolides tended to be less active against isolates recovered from non-invasive sites than against those isolated from invasive sites. Imipenem was the most active beta-lactam against penicillin-resistant isolates. Ofloxacin, vancomycin and teicoplanin showed good in-vitro activity against all isolates, with MIC90s of 2, 1 and 0.25 mg/L, respectively. None of these isolates displayed high-level resistance to gentamicin and most isolates were susceptible to chloramphenicol. These results indicate the species-related variability of susceptibility, especially to penicillin, macrolides and tetracycline. In addition to S. mitis, S. oralis also displayed high rates of resistance to penicillin and macrolides. The difference in susceptibilities between species of viridans streptococci indicates the importance of accurate identification and the need for continuing surveillance of antimicrobial resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687100     DOI: 10.1093/jac/41.6.621

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  33 in total

1.  Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes.

Authors:  T Ono; S Shiota; K Hirota; K Nemoto; T Tsuchiya; Y Miyake
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

2.  Evaluation of the PASCO strep plus broth microdilution antimicrobial susceptibility panels for testing Streptococcus pneumoniae and other Streptococcal species.

Authors:  M J Mohammed; F C Tenover
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

3.  Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings.

Authors:  J Leistevuo; H Järvinen; M Osterblad; T Leistevuo; P Huovinen; J Tenovuo
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Contributors to antibiotic resistance. Antibiotics should not be first treatment for acne.

Authors:  M J Cheesbrough
Journal:  BMJ       Date:  1999-03-06

5.  Antimicrobial susceptibilities and clinical sources of Facklamia species.

Authors:  L LaClaire; R Facklam
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

6.  Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000.

Authors:  Andrea S Gershon; Joyce C S de Azavedo; Allison McGeer; Krystyna I Ostrowska; Deirdre Church; Daryl J Hoban; Godfrey K M Harding; Karl Weiss; Lewis Abbott; Fiona Smaill; Marie Gourdeau; Gilles Murray; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

7.  Identification of clinically relevant viridans group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region.

Authors:  Chao Chien Chen; Lee Jene Teng; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

8.  Genetic basis of erythromycin resistance in oral bacteria.

Authors:  A Villedieu; M L Diaz-Torres; A P Roberts; N Hunt; R McNab; D A Spratt; M Wilson; P Mullany
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

9.  New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.

Authors:  María-José Ferrándiz; Carmen Ardanuy; Josefina Liñares; Luz Balsalobre; María Teresa García; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

10.  Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution.

Authors:  Eiman M Mokaddas; Nathaneal O Salako; Leeba Philip; Vincent O Rotimi
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.